Mianserin for the rapid improvement of chronic akathisia in a schizophrenia patient [1]

European Psychiatry

Volumn 19, Issue 4, 2004, Pages 237-238

  Stryjer, Rafael ^a,b   Grupper, Daniel ^a,b   Strous, Rael ^a,b   Poyurovsky, Michael ^c,d   Weizman, Abraham ^b,e  

^a BEER YAAKOV MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Technion Medical School   (Israel)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^e GEHA MENTAL HEALTH CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BIPERIDEN; DIAZEPAM; FLUPHENAZINE; MIANSERIN; PROPRANOLOL; TRAZODONE;

ADULT; AKATHISIA; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG RESPONSE; DRUG WITHDRAWAL; HUMAN; INJECTION; LETTER; MALE; MEDICAL ASSESSMENT; MENTAL PATIENT; MOTOR DYSFUNCTION; OUTPATIENT; PRIORITY JOURNAL; RATING SCALE; RECURRENT DISEASE; SCHIZOPHRENIA; SCORING SYSTEM;

AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; FLUPHENAZINE; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA; SEROTONIN ANTAGONISTS;

EID: 2942652962     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2003.12.008     Document Type: Letter

References (7)

1. Barnes T.R., Braude W.S. Akathisia variants and tardive dyskinesia. Arch Gen Psychiatry. 42:1985;874-878
2. Jones N., Duxon M.S., King S.M. 5H2C receptor mediation of unconditioned escape behavior in the unstable elevated exposed plus maze. Psychopharmacology (Berl). 164:2002;214-220
3. Mihara K., Yasui-furukori N., Kondo T., Ishida M., Ono S., Ohkubo T., et al. Relationship between plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine, and its clinical effect in depressed patients. Ther Drug Monit. 24:2002;563-566
4. Poyurovsky M., Weizman A. Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: a new approach to an old problem. Br J Psychiatry. 179:2001;4-8
5. Spivak B., Mester R., Abesgaus J., Wittenberg N., Adlersberg S., Gonen N., et al. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients. J Clin Psychiatry. 58:1997;318-322
6. Stryjer R., Strous R.D., Bar F., Poyurovsky M., Weizman A., Kotler M. Treatment of neuroleptic induced akathisia with the 5HT2A antagonist trazodone. Clin Neuropharmacol. 26:(3):2003;137-141
7. Zhang W., Perry K.W., Wong D.T., Potts B.D., Bao J., Tollefson G.D., et al. Synergic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex. Neuropsychopharmacology. 23:2000;250-262